Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment
Clinical trial NCT01613690 · COMPLETED
Trial details
- NCT number
- NCT01613690
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2010-11-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.